Upgrades
According to Deutsche Bank, the prior rating for Scorpio Tankers Inc (NYSE:STNG) was changed from Sell to Hold. For the second quarter, Scorpio Tankers had an EPS of $3.13, compared to year-ago quarter EPS of $0.94. The stock has a 52-week-high of $46.30 and a 52-week-low of $11.02. At the end of the last trading period, Scorpio Tankers closed at $40.74.
Credit Suisse upgraded the previous rating for Algonquin Power & Utilities Corp (NYSE:AQN) from Neutral to Outperform. For the second quarter, Algonquin Power had an EPS of $0.16, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $16.01 and a 52-week-low of $10.38. At the end of the last trading period, Algonquin Power closed at $10.48.
For AmerisourceBergen Corp (NYSE:ABC), B of A Securities upgraded the previous rating of Neutral to Buy. AmerisourceBergen earned $2.62 in the third quarter, compared to $2.16 in the year-ago quarter. The current stock performance of AmerisourceBergen shows a 52-week-high of $167.19 and a 52-week-low of $127.94. Moreover, at the end of the last trading period, the closing price was at $137.62.
According to Morgan Stanley, the prior rating for Amgen Inc (NASDAQ:AMGN) was changed from Equal-Weight to Overweight. For the second quarter, Amgen had an EPS of $4.65, compared to year-ago quarter EPS of $4.38. At the moment, the stock has a 52-week-high of $258.45 and a 52-week-low of $214.39. Amgen closed at $232.15 at the end of the last trading period.
Benchmark upgraded the previous rating for Getty Images Holdings Inc (NYSE:GETY) from Hold to Buy. Getty Images Holdings earned $0.29 in the second quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Getty Images Holdings shows a 52-week-high of $37.88 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $6.27.
For Seagen Inc (NASDAQ:SGEN), BMO Capital upgraded the previous rating of Market Perform to Outperform. In the second quarter, Seagen showed an EPS of $0.73, compared to $0.47 from the year-ago quarter. The current stock performance of Seagen shows a 52-week-high of $183.00 and a 52-week-low of $105.43. Moreover, at the end of the last trading period, the closing price was at $130.95.
For Lululemon Athletica Inc (NASDAQ:LULU), Piper Sandler upgraded the previous rating of Neutral to Overweight. Lululemon Athletica earned $2.20 in the second quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Lululemon Athletica shows a 52-week-high of $410.70 and a 52-week-low of $251.51. Moreover, at the end of the last trading period, the closing price was at $289.85.
According to Piper Sandler, the prior rating for e.l.f. Beauty Inc (NYSE:ELF) was changed from Neutral to Overweight. For the first quarter, e.l.f. Beauty had an EPS of $0.39, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $41.31 and a 52-week-low of $20.49. At the end of the last trading period, e.l.f. Beauty closed at $37.49.
Wells Fargo upgraded the previous rating for Marvell Technology Inc (NASDAQ:MRVL) from Equal-Weight to Overweight. For the second quarter, Marvell Tech had an EPS of $0.57, compared to year-ago quarter EPS of $0.34. The current stock performance of Marvell Tech shows a 52-week-high of $91.78 and a 52-week-low of $39.20. Moreover, at the end of the last trading period, the closing price was at $40.30.
According to SVB Leerink, the prior rating for scPharmaceuticals Inc (NASDAQ:SCPH) was changed from Market Perform to Outperform. scPharmaceuticals earned $0.35 in the second quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.80 and a 52-week-low of $3.68. scPharmaceuticals closed at $4.02 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
According to UBS, the prior rating for BlackRock Inc (NYSE:BLK) was changed from Buy to Neutral. BlackRock earned $7.36 in the second quarter, compared to $10.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $927.48 and a 52-week-low of $541.33. BlackRock closed at $545.54 at the end of the last trading period.
For ACM Research Inc (NASDAQ:ACMR), Jefferies downgraded the previous rating of Buy to Underperform. ACM Research earned $0.22 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $91.59 and a 52-week-low of $8.54. At the end of the last trading period, ACM Research closed at $9.04.
According to Scotiabank, the prior rating for Mechel PAO (NYSE:MTL) was changed from Sector Outperform to Sector Perform. NoneThe stock has a 52-week-high of $4.32 and a 52-week-low of $1.88. At the end of the last trading period, Mechel PAO closed at $2.25.
For Vitru Ltd (NASDAQ:VTRU), Goldman Sachs downgraded the previous rating of Buy to Neutral. Vitru earned $0.47 in the second quarter, compared to $0.18 in the year-ago quarter.
Credit Suisse downgraded the previous rating for Cogent Communications Holdings Inc (NASDAQ:CCOI) from Outperform to Neutral. Cogent Comms Hldgs earned $0.24 in the second quarter, compared to $0.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.08 and a 52-week-low of $49.02. Cogent Comms Hldgs closed at $51.53 at the end of the last trading period.
According to B of A Securities, the prior rating for SunPower Corp (NASDAQ:SPWR) was changed from Neutral to Underperform. SunPower earned $0.03 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.42 and a 52-week-low of $12.78. SunPower closed at $21.47 at the end of the last trading period.
For Zoom Video Communications Inc (NASDAQ:ZM), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Zoom Video Comms earned $1.05 in the second quarter, compared to $1.36 in the year-ago quarter. The current stock performance of Zoom Video Comms shows a 52-week-high of $184.91 and a 52-week-low of $71.69. Moreover, at the end of the last trading period, the closing price was at $73.72.
For Meta Platforms Inc (NASDAQ:META), Atlantic Equities downgraded the previous rating of Overweight to Neutral. In the second quarter, Meta Platforms showed an EPS of $2.46, compared to $3.61 from the year-ago quarter. The current stock performance of Meta Platforms shows a 52-week-high of $199.45 and a 52-week-low of $11.73. Moreover, at the end of the last trading period, the closing price was at $133.79.
According to Wells Fargo, the prior rating for Skyworks Solutions Inc (NASDAQ:SWKS) was changed from Overweight to Equal-Weight. In the third quarter, Skyworks Solutions showed an EPS of $2.44, compared to $2.15 from the year-ago quarter. The current stock performance of Skyworks Solutions shows a 52-week-high of $163.47 and a 52-week-low of $83.28. Moreover, at the end of the last trading period, the closing price was at $83.92.
Wells Fargo downgraded the previous rating for Qorvo Inc (NASDAQ:QRVO) from Overweight to Equal-Weight. For the first quarter, Qorvo had an EPS of $2.25, compared to year-ago quarter EPS of $2.83. The current stock performance of Qorvo shows a 52-week-high of $163.12 and a 52-week-low of $79.36. Moreover, at the end of the last trading period, the closing price was at $81.96.
See all analyst ratings downgrades.
Initiations
With a Equal-Weight rating, Morgan Stanley initiated coverage on Nurix Therapeutics Inc (NASDAQ:NRIX). The price target seems to have been set at $11.00 for Nurix Therapeutics. For the third quarter, Nurix Therapeutics had an EPS of $0.90, compared to year-ago quarter EPS of $0.65. The current stock performance of Nurix Therapeutics shows a 52-week-high of $30.52 and a 52-week-low of $7.52. Moreover, at the end of the last trading period, the closing price was at $10.99.
JP Morgan initiated coverage on CompoSecure Inc (NASDAQ:CMPO) with an Overweight rating. The price target for CompoSecure is set to $10.00. The stock has a 52-week-high of $9.09 and a 52-week-low of $4.72. At the end of the last trading period, CompoSecure closed at $5.26.
With a Buy rating, Canaccord Genuity initiated coverage on Rapid7 Inc (NASDAQ:RPD). The price target seems to have been set at $60.00 for Rapid7. For the second quarter, Rapid7 had an EPS of $0.01, compared to year-ago quarter EPS of $0.07. The stock has a 52-week-high of $118.42 and a 52-week-low of $39.67. At the end of the last trading period, Rapid7 closed at $39.89.
With a Buy rating, Canaccord Genuity initiated coverage on Qualys Inc (NASDAQ:QLYS). The price target seems to have been set at $180.00 for Qualys. For the second quarter, Qualys had an EPS of $0.89, compared to year-ago quarter EPS of $0.79. At the moment, the stock has a 52-week-high of $162.36 and a 52-week-low of $108.10. Qualys closed at $131.12 at the end of the last trading period.
With a Buy rating, Maxim Group initiated coverage on Xperi Inc (NYSE:XPER). The price target seems to have been set at $23.00 for Xperi. Xperi earned $0.52 in the second quarter, compared to $0.61 in the year-ago quarter. The stock has a 52-week-high of $19.90 and a 52-week-low of $13.30. At the end of the last trading period, Xperi closed at $13.74.
Wedbush initiated coverage on Brown-Forman Corp (NYSE:BF) with a Neutral rating. The price target for Brown-Forman is set to $70.00.
With a Neutral rating, Mizuho initiated coverage on Eastman Chemical Co (NYSE:EMN). The price target seems to have been set at $91.00 for Eastman Chemical. In the second quarter, Eastman Chemical showed an EPS of $2.83, compared to $2.46 from the year-ago quarter. The current stock performance of Eastman Chemical shows a 52-week-high of $129.47 and a 52-week-low of $69.91. Moreover, at the end of the last trading period, the closing price was at $71.78.
With a Buy rating, Goldman Sachs initiated coverage on Enovis Corp (NYSE:ENOV). The price target seems to have been set at $57.00 for Enovis. For the second quarter, Enovis had an EPS of $0.59, compared to year-ago quarter EPS of $1.68. The stock has a 52-week-high of $72.13 and a 52-week-low of $44.77. At the end of the last trading period, Enovis closed at $44.86.
With a Market Perform rating, Cowen & Co. initiated coverage on Texas Instruments Inc (NASDAQ:TXN). The price target seems to have been set at $170.00 for Texas Instruments. Texas Instruments earned $2.45 in the second quarter, compared to $2.05 in the year-ago quarter. The stock has a 52-week-high of $192.10 and a 52-week-low of $144.46. At the end of the last trading period, Texas Instruments closed at $156.79.
Cowen & Co. initiated coverage on Analog Devices Inc (NASDAQ:ADI) with an Outperform rating. The price target for Analog Devices is set to $180.00. For the third quarter, Analog Devices had an EPS of $2.52, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $180.01 and a 52-week-low of $138.50. Analog Devices closed at $140.90 at the end of the last trading period.
With an Overweight rating, Morgan Stanley initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA). The price target seems to have been set at $84.00 for Intellia Therapeutics. Intellia Therapeutics earned $1.33 in the second quarter, compared to $1.01 in the year-ago quarter. The current stock performance of Intellia Therapeutics shows a 52-week-high of $119.65 and a 52-week-low of $37.08. Moreover, at the end of the last trading period, the closing price was at $54.31.
Morgan Stanley initiated coverage on United Therapeutics Corp (NASDAQ:UTHR) with an Overweight rating. The price target for United Therapeutics is set to $288.00. In the second quarter, United Therapeutics showed an EPS of $2.41, compared to $3.65 from the year-ago quarter. The stock has a 52-week-high of $245.48 and a 52-week-low of $158.38. At the end of the last trading period, United Therapeutics closed at $205.95.
Morgan Stanley initiated coverage on Arcus Biosciences Inc (NYSE:RCUS) with an Overweight rating. The price target for Arcus Biosciences is set to $40.00. Arcus Biosciences earned $0.93 in the second quarter, compared to $1.09 in the year-ago quarter. The stock has a 52-week-high of $42.05 and a 52-week-low of $16.74. At the end of the last trading period, Arcus Biosciences closed at $26.15.
With an Underweight rating, Morgan Stanley initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP). The price target seems to have been set at $37.00 for CRISPR Therapeutics. For the second quarter, CRISPR Therapeutics had an EPS of $2.40, compared to year-ago quarter EPS of $9.44. The stock has a 52-week-high of $86.95 and a 52-week-low of $42.51. At the end of the last trading period, CRISPR Therapeutics closed at $60.82.
Morgan Stanley initiated coverage on C4 Therapeutics Inc (NASDAQ:CCCC) with an Underweight rating. The price target for C4 Therapeutics is set to $6.00. For the second quarter, C4 Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.51. The stock has a 52-week-high of $33.76 and a 52-week-low of $4.84. At the end of the last trading period, C4 Therapeutics closed at $7.73.
Morgan Stanley initiated coverage on Revance Therapeutics Inc (NASDAQ:RVNC) with a Equal-Weight rating. The price target for Revance Therapeutics is set to $27.00. Revance Therapeutics earned $0.88 in the second quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $30.95 and a 52-week-low of $11.27. At the end of the last trading period, Revance Therapeutics closed at $28.89.
UBS initiated coverage on Rani Therapeutics Holdings Inc (NASDAQ:RANI) with a Buy rating. The price target for Rani Therapeutics Hldgs is set to $15.00. For the second quarter, Rani Therapeutics Hldgs had an EPS of $0.31, compared to year-ago quarter EPS of $0.12. The current stock performance of Rani Therapeutics Hldgs shows a 52-week-high of $27.13 and a 52-week-low of $6.73. Moreover, at the end of the last trading period, the closing price was at $7.00.
UBS initiated coverage on Neurocrine Biosciences Inc (NASDAQ:NBIX) with a Buy rating. The price target for Neurocrine Biosciences is set to $136.00. In the second quarter, Neurocrine Biosciences showed an EPS of $0.84, compared to $0.63 from the year-ago quarter. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $113.63 and a 52-week-low of $71.88. Moreover, at the end of the last trading period, the closing price was at $106.84.
UBS initiated coverage on Cytokinetics Inc (NASDAQ:CYTK) with a Buy rating. The price target for Cytokinetics is set to $80.00. For the second quarter, Cytokinetics had an EPS of $0.23, compared to year-ago quarter EPS of $0.86. The current stock performance of Cytokinetics shows a 52-week-high of $55.80 and a 52-week-low of $29.26. Moreover, at the end of the last trading period, the closing price was at $47.23.
With an Underweight rating, Barclays initiated coverage on Roblox Corp (NYSE:RBLX). The price target seems to have been set at $20.00 for Roblox. In the second quarter, Roblox showed an EPS of $0.30, compared to $0.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $103.79 and a 52-week-low of $21.65. Roblox closed at $35.40 at the end of the last trading period.
With a Neutral rating, Citigroup initiated coverage on Corebridge Financial Inc (NYSE:CRBG). The price target seems to have been set at $23.00 for Corebridge Financial. The stock has a 52-week-high of $22.00 and a 52-week-low of $19.14. At the end of the last trading period, Corebridge Financial closed at $19.69.
Wells Fargo initiated coverage on Elastic NV (NYSE:ESTC) with an Underweight rating. The price target for Elastic is set to $73.00. Elastic earned $0.15 in the first quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Elastic shows a 52-week-high of $124.25 and a 52-week-low of $50.74. Moreover, at the end of the last trading period, the closing price was at $66.78.
Bernstein initiated coverage on Snowflake Inc (NYSE:SNOW) with a Market Perform rating. Snowflake earned $0.01 in the second quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $344.00 and a 52-week-low of $110.27. Snowflake closed at $159.05 at the end of the last trading period.
Wells Fargo initiated coverage on Splunk Inc (NASDAQ:SPLK) with an Overweight rating. The price target for Splunk is set to $95.00. Splunk earned $0.09 in the second quarter, compared to $0.62 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $150.79 and a 52-week-low of $71.11. Moreover, at the end of the last trading period, the closing price was at $72.12.
With an Overweight rating, Wells Fargo initiated coverage on Datadog Inc (NASDAQ:DDOG). The price target seems to have been set at $120.00 for Datadog. Datadog earned $0.24 in the second quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $184.70 and a 52-week-low of $81.12. Datadog closed at $84.02 at the end of the last trading period.
With an Overweight rating, Wells Fargo initiated coverage on Dynatrace Inc (NYSE:DT). The price target seems to have been set at $45.00 for Dynatrace. Dynatrace earned $0.18 in the first quarter, compared to $0.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.17 and a 52-week-low of $29.41. Dynatrace closed at $34.69 at the end of the last trading period.
With a Buy rating, Deutsche Bank initiated coverage on International Seaways Inc (NYSE:INSW). The price target seems to have been set at $40.00 for International Seaways. International Seaways earned $1.43 in the second quarter, compared to $0.51 in the year-ago quarter. The current stock performance of International Seaways shows a 52-week-high of $36.72 and a 52-week-low of $13.05. Moreover, at the end of the last trading period, the closing price was at $34.31.
With a Buy rating, Goldman Sachs initiated coverage on Warner Music Group Corp (NASDAQ:WMG). The price target seems to have been set at $32.00 for Warner Music Group. For the third quarter, Warner Music Group had an EPS of $0.28, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $44.64 and a 52-week-low of $22.08. Warner Music Group closed at $22.35 at the end of the last trading period.
Mizuho initiated coverage on Celanese Corp (NYSE:CE) with a Neutral rating. The price target for Celanese is set to $116.00. Celanese earned $4.99 in the second quarter, compared to $5.02 in the year-ago quarter. The current stock performance of Celanese shows a 52-week-high of $176.50 and a 52-week-low of $86.70. Moreover, at the end of the last trading period, the closing price was at $91.85.
Oppenheimer initiated coverage on POINT Biopharma Global Inc (NASDAQ:PNT) with an Outperform rating. The price target for POINT Biopharma Global is set to $20.00. For the second quarter, POINT Biopharma Global had an EPS of $0.27, compared to year-ago quarter EPS of $0.15. The current stock performance of POINT Biopharma Global shows a 52-week-high of $10.98 and a 52-week-low of $5.22. Moreover, at the end of the last trading period, the closing price was at $7.28.
With an Outperform rating, Wedbush initiated coverage on Keurig Dr Pepper Inc (NASDAQ:KDP). The price target seems to have been set at $43.00 for Keurig Dr Pepper. In the second quarter, Keurig Dr Pepper showed an EPS of $0.39, compared to $0.38 from the year-ago quarter. The stock has a 52-week-high of $41.31 and a 52-week-low of $33.35. At the end of the last trading period, Keurig Dr Pepper closed at $36.97.
With a Neutral rating, Wedbush initiated coverage on Monster Beverage Corp (NASDAQ:MNST). The price target seems to have been set at $95.00 for Monster Beverage. Monster Beverage earned $0.51 in the second quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $99.81 and a 52-week-low of $71.78. At the end of the last trading period, Monster Beverage closed at $91.02.
With an Outperform rating, Wedbush initiated coverage on Coca-Cola Co (NYSE:KO). The price target seems to have been set at $63.00 for Coca-Cola. Coca-Cola earned $0.70 in the second quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $67.20 and a 52-week-low of $54.02. Coca-Cola closed at $54.39 at the end of the last trading period.
With a Neutral rating, Wedbush initiated coverage on Boston Beer Co Inc (NYSE:SAM). The price target seems to have been set at $350.00 for Boston Beer Co. Boston Beer Co earned $4.31 in the second quarter, compared to $4.75 in the year-ago quarter. The current stock performance of Boston Beer Co shows a 52-week-high of $535.00 and a 52-week-low of $287.00. Moreover, at the end of the last trading period, the closing price was at $348.25.
Wedbush initiated coverage on The Duckhorn Portfolio Inc (NYSE:NAPA) with an Outperform rating. The price target for Duckhorn Portfolio is set to $18.00. Duckhorn Portfolio earned $0.08 in the fourth quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.57 and a 52-week-low of $12.64. Duckhorn Portfolio closed at $14.43 at the end of the last trading period.
With an Outperform rating, Wedbush initiated coverage on PepsiCo Inc (NASDAQ:PEP). The price target seems to have been set at $185.00 for PepsiCo. PepsiCo earned $1.86 in the second quarter, compared to $1.72 in the year-ago quarter. The stock has a 52-week-high of $181.07 and a 52-week-low of $153.37. At the end of the last trading period, PepsiCo closed at $161.82.
With an Outperform rating, Wedbush initiated coverage on MGP Ingredients Inc (NASDAQ:MGPI). The price target seems to have been set at $125.00 for MGP Ingredients. For the second quarter, MGP Ingredients had an EPS of $1.15, compared to year-ago quarter EPS of $1.27. The stock has a 52-week-high of $117.01 and a 52-week-low of $73.02. At the end of the last trading period, MGP Ingredients closed at $105.04.
Wedbush initiated coverage on Constellation Brands Inc (NYSE:STZ) with an Outperform rating. The price target for Constellation Brands is set to $275.00. Constellation Brands earned $3.17 in the second quarter, compared to $2.38 in the year-ago quarter. The current stock performance of Constellation Brands shows a 52-week-high of $261.52 and a 52-week-low of $207.59. Moreover, at the end of the last trading period, the closing price was at $221.24.
With a Neutral rating, Wedbush initiated coverage on Molson Coors Beverage Co (NYSE:TAP). The price target seems to have been set at $50.00 for Molson Coors Beverage. In the second quarter, Molson Coors Beverage showed an EPS of $1.19, compared to $1.58 from the year-ago quarter. The stock has a 52-week-high of $60.12 and a 52-week-low of $46.47. At the end of the last trading period, Molson Coors Beverage closed at $47.31.
Wedbush initiated coverage on Celsius Holdings Inc (NASDAQ:CELH) with a Neutral rating. The price target for Celsius Holdings is set to $90.00. In the second quarter, Celsius Holdings showed an EPS of $0.12, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $118.19 and a 52-week-low of $38.31. Celsius Holdings closed at $89.24 at the end of the last trading period.
Wolfe Research initiated coverage on Virgin Galactic Holdings Inc (NYSE:SPCE) with an Underperform rating. The price target for Virgin Galactic Hldgs is set to $4.00. In the second quarter, Virgin Galactic Hldgs showed an EPS of $0.43, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.73 and a 52-week-low of $4.68. Virgin Galactic Hldgs closed at $4.92 at the end of the last trading period.
With an Underperform rating, Wolfe Research initiated coverage on Spirit AeroSystems Holdings Inc (NYSE:SPR). The price target seems to have been set at $24.00 for Spirit AeroSystems Hldgs. Spirit AeroSystems Hldgs earned $1.21 in the second quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $53.31 and a 52-week-low of $21.51. Moreover, at the end of the last trading period, the closing price was at $24.95.
With an Underperform rating, Wolfe Research initiated coverage on Triumph Group Inc (NYSE:TGI). The price target seems to have been set at $9.00 for Triumph Group. In the first quarter, Triumph Group showed an EPS of $0.12, compared to $0.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.85 and a 52-week-low of $8.58. Triumph Group closed at $8.93 at the end of the last trading period.
Wolfe Research initiated coverage on Woodward Inc (NASDAQ:WWD) with an Outperform rating. The price target for Woodward is set to $100.00. Woodward earned $0.64 in the third quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $129.12 and a 52-week-low of $79.26. At the end of the last trading period, Woodward closed at $84.43.
For Barnes Group Inc (NYSE:B), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. For the second quarter, Barnes Gr had an EPS of $0.56, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $48.79 and a 52-week-low of $27.93. At the end of the last trading period, Barnes Gr closed at $32.06.
Wolfe Research initiated coverage on TransDigm Group Inc (NYSE:TDG) with an Outperform rating. The price target for TransDigm Gr is set to $650.00. TransDigm Gr earned $4.85 in the third quarter, compared to $3.33 in the year-ago quarter. The stock has a 52-week-high of $684.72 and a 52-week-low of $500.08. At the end of the last trading period, TransDigm Gr closed at $531.52.
Wolfe Research initiated coverage on Raytheon Technologies Corp (NYSE:RTX) with a Peer Perform rating. Raytheon Technologies earned $1.16 in the second quarter, compared to $1.03 in the year-ago quarter. The current stock performance of Raytheon Technologies shows a 52-week-high of $106.02 and a 52-week-low of $80.27. Moreover, at the end of the last trading period, the closing price was at $84.16.
With an Outperform rating, Wolfe Research initiated coverage on Northrop Grumman Corp (NYSE:NOC). The price target seems to have been set at $565.00 for Northrop Grumman. Northrop Grumman earned $6.06 in the second quarter, compared to $6.42 in the year-ago quarter. The current stock performance of Northrop Grumman shows a 52-week-high of $515.49 and a 52-week-low of $364.62. Moreover, at the end of the last trading period, the closing price was at $503.83.
Wolfe Research initiated coverage on Curtiss-Wright Corp (NYSE:CW) with an Outperform rating. The price target for Curtiss-Wright is set to $170.00. Curtiss-Wright earned $1.83 in the second quarter, compared to $1.56 in the year-ago quarter. The current stock performance of Curtiss-Wright shows a 52-week-high of $162.98 and a 52-week-low of $124.37. Moreover, at the end of the last trading period, the closing price was at $148.43.
Wolfe Research initiated coverage on Lockheed Martin Corp (NYSE:LMT) with a Peer Perform rating. Lockheed Martin earned $6.32 in the second quarter, compared to $6.52 in the year-ago quarter. At the moment, the stock has a 52-week-high of $479.99 and a 52-week-low of $353.03. Lockheed Martin closed at $409.99 at the end of the last trading period.
Wolfe Research initiated coverage on Embraer SA (NYSE:ERJ) with an Outperform rating. The price target for Embraer is set to $14.00. In the second quarter, Embraer showed an EPS of $0.21, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.08 and a 52-week-low of $7.91. Embraer closed at $9.55 at the end of the last trading period.
Wolfe Research initiated coverage on L3Harris Technologies Inc (NYSE:LHX) with a Peer Perform rating. In the second quarter, L3Harris Technologies showed an EPS of $3.23, compared to $3.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $279.71 and a 52-week-low of $206.04. L3Harris Technologies closed at $230.44 at the end of the last trading period.
With an Outperform rating, Wolfe Research initiated coverage on General Dynamics Corp (NYSE:GD). The price target seems to have been set at $265.00 for General Dynamics. General Dynamics earned $2.75 in the second quarter, compared to $2.61 in the year-ago quarter. The current stock performance of General Dynamics shows a 52-week-high of $254.99 and a 52-week-low of $200.65. Moreover, at the end of the last trading period, the closing price was at $225.41.
For Hexcel Corp (NYSE:HXL), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. In the second quarter, Hexcel showed an EPS of $0.33, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $65.82 and a 52-week-low of $47.38. Hexcel closed at $54.06 at the end of the last trading period.
Wolfe Research initiated coverage on Heico Corp (NYSE:HEI) with a Peer Perform rating. In the third quarter, Heico showed an EPS of $0.60, compared to $0.56 from the year-ago quarter. The current stock performance of Heico shows a 52-week-high of $165.61 and a 52-week-low of $126.95. Moreover, at the end of the last trading period, the closing price was at $148.92.
Wolfe Research initiated coverage on Huntington Ingalls Industries Inc (NYSE:HII) with an Outperform rating. The price target for Huntington Ingalls Indus is set to $315.00. For the second quarter, Huntington Ingalls Indus had an EPS of $4.44, compared to year-ago quarter EPS of $3.20. The stock has a 52-week-high of $243.46 and a 52-week-low of $177.20. At the end of the last trading period, Huntington Ingalls Indus closed at $235.06.
Wolfe Research initiated coverage on Boeing Co (NYSE:BA) with an Outperform rating. The price target for Boeing is set to $180.00. In the second quarter, Boeing showed an EPS of $0.37, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $229.67 and a 52-week-low of $113.02. Boeing closed at $131.90 at the end of the last trading period.
